ERBB2 and urothelial carcinoma: At present, however, there are no official recommendations from international organizations (WHO, AJCC, ESMO, EAU) for mandatory HER2 testing in urothelial carcinoma—it is performed at the clinician’s discretion, mainly when there is a specific clinical need.